We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 545

Biotech boards dominated by men

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 30 2014

A Liftstream analysis reportedly shows that the average Board of Directors in the biotechnology sphere is roughly 90 percent male and more than half

Nagoya genetic resources protocol enters into force

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • October 30 2014

The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization entered into force

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 30 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry titled "Circumstances that Constitute Delaying, Denying, Limiting

Third Circuit revives shareholder suit over dissolved biotech company

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 30 2014

A divided Third Circuit Court of Appeals panel has reversed a district court ruling dismissing a shareholder's lawsuit against individuals and a

Ninth Circuit okays pharma waste disposal ordinance

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 30 2014

The Ninth Circuit Court of Appeals has upheld the validity of an Alameda County ordinance that requires prescription drug producers that sell brand

Non-practicing entity’s suit to halt FTC investigation dismissed

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

A federal court in Texas has dismissed for lack of standing and ripeness and for failure to exhaust administrative remedies a declaratory judgment

Public watchdog calls on FDA to issue “revolving door” guidance

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

Public Citizen recently called on the U.S. Food and Drug Administration (FDA) to take certain steps that would both prohibit the practice of advisory

Shire Pharmaceuticals settles FCA claims for $56.5 million

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

Without admitting liability, Wayne, Pennsylvania-based Shire Pharmaceuticals LLC has entered a settlement agreement with the U.S. Department of

FDA contends Twitter not off limits for pharmaceutical cos.

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

While the U.S. Food and Drug Administration (FDA) has extended the deadline for comments on its draft guidance for drug and medical device makers

Newsbytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

The U.S. Patent and Trademark Office extends the deadline for applications under its Patents for Humanity Program, "which recognizes patent holders